Sophora flavescens root

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Sophora flavescens root
Accession Number
DB14565
Description
Not Available
Type
Biotech
Groups
Experimental
Synonyms
  • Bitter root
  • Dogol-evs root
  • Ku shen
  • Kushen
  • Lightyellow sophora root
  • Shargal lider root
  • Shrubby sophora root
  • Sle-tres root
  • Sofora zheltovataya root
  • Sophora angustifolia root
  • Sophora root
  • Sophorae flavescentis radix
  • Sophorae radix

Pharmacology

Indication
Not Available
Contraindications & Blackbox Warnings
Learn about our commercial Contraindications & Blackbox Warnings data.
Learn More
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half-life
Not Available
Clearance
Not Available
Adverse Effects
Learn about our commercial Adverse Effects data.
Learn More
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Purchasing individual compounds or compound libraries for your research?
Learn More
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Lacto Bella YSophora flavescens root (0.0015 g/100mL) + Lactobacillus reuteri (0.6 g/100mL) + Lavender oil (0.8 g/100mL) + Sodium chloride (0.3 g/100mL)GelVaginalBella Lab Co., Ltd.2018-04-27Not applicableUS flag
Unapproved/Other Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Lacto Bella YSophora flavescens root (0.0015 g/100mL) + Lactobacillus reuteri (0.6 g/100mL) + Lavender oil (0.8 g/100mL) + Sodium chloride (0.3 g/100mL)GelVaginalBella Lab Co., Ltd.2018-04-27Not applicableUS flag

Categories

Drug Categories
Classification
Not classified

Chemical Identifiers

UNII
IYR6K8KQ5K
CAS number
Not Available

References

General References
Not Available
RxNav
1307593

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
4RecruitingTreatmentRadiation-induced Oral Mucositis1
4Unknown StatusPreventionLung Cancers1
Not AvailableCompletedNot AvailableAdverse Drug Events / Adverse Drug Reaction (ADR) / Safety Surveillance / Severe Adverse Events / Severe Adverse Reactions1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
GelVaginal
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created on July 20, 2018 10:22 / Updated on June 12, 2020 10:53

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Logo pink
Stay in the know!
As part of our commitment to providing the most up-to-date drug information, we will be releasing #DrugBankUpdates with our newly added curated drug pages.
#DrugBankUpdates